A large and apprently artificial collection of diverse kinetoplastid protein kinases. A subfamily has 2TM regions, but the majority is cytoplasmic.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 11 |
GO:0042995 | cell projection | 2 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 11 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005952 | cAMP-dependent protein kinase complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0051286 | cell tip | 3 | 1 |
GO:0060187 | cell pole | 2 | 1 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 1 |
GO:0140535 | intracellular protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1902554 | serine/threonine protein kinase complex | 6 | 1 |
GO:1902911 | protein kinase complex | 5 | 1 |
GO:1990234 | transferase complex | 3 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4H8V2
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 22 |
GO:0006793 | phosphorus metabolic process | 3 | 22 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 22 |
GO:0006807 | nitrogen compound metabolic process | 2 | 22 |
GO:0008152 | metabolic process | 1 | 22 |
GO:0009987 | cellular process | 1 | 22 |
GO:0016310 | phosphorylation | 5 | 22 |
GO:0019538 | protein metabolic process | 3 | 22 |
GO:0036211 | protein modification process | 4 | 22 |
GO:0043170 | macromolecule metabolic process | 3 | 22 |
GO:0043412 | macromolecule modification | 4 | 22 |
GO:0044237 | cellular metabolic process | 2 | 22 |
GO:0044238 | primary metabolic process | 2 | 22 |
GO:0071704 | organic substance metabolic process | 2 | 22 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 22 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018209 | peptidyl-serine modification | 6 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 22 |
GO:0003824 | catalytic activity | 1 | 22 |
GO:0004672 | protein kinase activity | 3 | 22 |
GO:0005488 | binding | 1 | 22 |
GO:0005524 | ATP binding | 5 | 22 |
GO:0016301 | kinase activity | 4 | 22 |
GO:0016740 | transferase activity | 2 | 22 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 22 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 22 |
GO:0017076 | purine nucleotide binding | 4 | 22 |
GO:0030554 | adenyl nucleotide binding | 5 | 22 |
GO:0032553 | ribonucleotide binding | 3 | 22 |
GO:0032555 | purine ribonucleotide binding | 4 | 22 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 22 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 22 |
GO:0036094 | small molecule binding | 2 | 22 |
GO:0043167 | ion binding | 2 | 22 |
GO:0043168 | anion binding | 3 | 22 |
GO:0097159 | organic cyclic compound binding | 2 | 22 |
GO:0097367 | carbohydrate derivative binding | 2 | 22 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 22 |
GO:1901265 | nucleoside phosphate binding | 3 | 22 |
GO:1901363 | heterocyclic compound binding | 2 | 22 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 10 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0004690 | cyclic nucleotide-dependent protein kinase activity | 5 | 1 |
GO:0004691 | cAMP-dependent protein kinase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 221 | 225 | PF00656 | 0.373 |
CLV_C14_Caspase3-7 | 233 | 237 | PF00656 | 0.354 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 239 | 241 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 493 | 495 | PF00675 | 0.676 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.286 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.311 |
CLV_PCSK_KEX2_1 | 239 | 241 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 280 | 282 | PF00082 | 0.355 |
CLV_PCSK_KEX2_1 | 475 | 477 | PF00082 | 0.612 |
CLV_PCSK_KEX2_1 | 493 | 495 | PF00082 | 0.619 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.338 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.269 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.394 |
CLV_PCSK_PC1ET2_1 | 280 | 282 | PF00082 | 0.422 |
CLV_PCSK_PC1ET2_1 | 475 | 477 | PF00082 | 0.664 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.343 |
CLV_PCSK_PC1ET2_1 | 9 | 11 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.264 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.315 |
DEG_Kelch_Keap1_1 | 429 | 434 | PF01344 | 0.449 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.162 |
DEG_SPOP_SBC_1 | 306 | 310 | PF00917 | 0.357 |
DOC_MAPK_gen_1 | 259 | 267 | PF00069 | 0.560 |
DOC_MAPK_gen_1 | 278 | 285 | PF00069 | 0.346 |
DOC_MAPK_gen_1 | 475 | 483 | PF00069 | 0.546 |
DOC_PP4_FxxP_1 | 138 | 141 | PF00568 | 0.267 |
DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 380 | 384 | PF00917 | 0.454 |
DOC_USP7_MATH_1 | 56 | 60 | PF00917 | 0.383 |
DOC_USP7_UBL2_3 | 147 | 151 | PF12436 | 0.428 |
DOC_USP7_UBL2_3 | 223 | 227 | PF12436 | 0.291 |
DOC_USP7_UBL2_3 | 471 | 475 | PF12436 | 0.580 |
DOC_USP7_UBL2_3 | 5 | 9 | PF12436 | 0.326 |
LIG_14-3-3_CanoR_1 | 218 | 226 | PF00244 | 0.237 |
LIG_14-3-3_CanoR_1 | 239 | 244 | PF00244 | 0.590 |
LIG_14-3-3_CanoR_1 | 389 | 398 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 66 | 70 | PF00244 | 0.253 |
LIG_14-3-3_CanoR_1 | 75 | 85 | PF00244 | 0.221 |
LIG_Actin_WH2_2 | 323 | 340 | PF00022 | 0.429 |
LIG_Actin_WH2_2 | 343 | 360 | PF00022 | 0.187 |
LIG_APCC_ABBAyCdc20_2 | 91 | 97 | PF00400 | 0.306 |
LIG_BRCT_BRCA1_1 | 313 | 317 | PF00533 | 0.322 |
LIG_Clathr_ClatBox_1 | 82 | 86 | PF01394 | 0.249 |
LIG_DLG_GKlike_1 | 239 | 247 | PF00625 | 0.476 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.342 |
LIG_FHA_1 | 179 | 185 | PF00498 | 0.314 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.271 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.350 |
LIG_FHA_1 | 72 | 78 | PF00498 | 0.233 |
LIG_FHA_2 | 307 | 313 | PF00498 | 0.474 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.282 |
LIG_LIR_Apic_2 | 135 | 141 | PF02991 | 0.326 |
LIG_LIR_Apic_2 | 146 | 152 | PF02991 | 0.326 |
LIG_LIR_Gen_1 | 341 | 352 | PF02991 | 0.367 |
LIG_LIR_LC3C_4 | 109 | 112 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 288 | 293 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 295 | 299 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 341 | 347 | PF02991 | 0.359 |
LIG_SH2_CRK | 149 | 153 | PF00017 | 0.249 |
LIG_SH2_CRK | 296 | 300 | PF00017 | 0.458 |
LIG_SH2_SRC | 214 | 217 | PF00017 | 0.214 |
LIG_SH2_SRC | 304 | 307 | PF00017 | 0.394 |
LIG_SH2_SRC | 444 | 447 | PF00017 | 0.484 |
LIG_SH2_SRC | 54 | 57 | PF00017 | 0.383 |
LIG_SH2_STAP1 | 244 | 248 | PF00017 | 0.400 |
LIG_SH2_STAT3 | 170 | 173 | PF00017 | 0.252 |
LIG_SH2_STAT3 | 244 | 247 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 304 | 307 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.439 |
LIG_SH3_3 | 195 | 201 | PF00018 | 0.290 |
LIG_SH3_3 | 250 | 256 | PF00018 | 0.505 |
LIG_SH3_3 | 478 | 484 | PF00018 | 0.513 |
LIG_SUMO_SIM_anti_2 | 349 | 355 | PF11976 | 0.431 |
LIG_SUMO_SIM_par_1 | 323 | 329 | PF11976 | 0.314 |
LIG_TRAF2_2 | 201 | 206 | PF00917 | 0.168 |
LIG_UBA3_1 | 273 | 280 | PF00899 | 0.468 |
LIG_UBA3_1 | 352 | 358 | PF00899 | 0.307 |
LIG_WRC_WIRS_1 | 413 | 418 | PF05994 | 0.350 |
MOD_CK1_1 | 28 | 34 | PF00069 | 0.317 |
MOD_CK1_1 | 365 | 371 | PF00069 | 0.350 |
MOD_CK1_1 | 393 | 399 | PF00069 | 0.355 |
MOD_CK1_1 | 406 | 412 | PF00069 | 0.354 |
MOD_CK1_1 | 429 | 435 | PF00069 | 0.576 |
MOD_CK1_1 | 451 | 457 | PF00069 | 0.605 |
MOD_CK1_1 | 467 | 473 | PF00069 | 0.658 |
MOD_CK2_1 | 306 | 312 | PF00069 | 0.350 |
MOD_CK2_1 | 428 | 434 | PF00069 | 0.449 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.265 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.322 |
MOD_GlcNHglycan | 249 | 252 | PF01048 | 0.573 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.468 |
MOD_GlcNHglycan | 405 | 408 | PF01048 | 0.373 |
MOD_GlcNHglycan | 466 | 469 | PF01048 | 0.730 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.316 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.594 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.372 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.229 |
MOD_GSK3_1 | 348 | 355 | PF00069 | 0.368 |
MOD_GSK3_1 | 358 | 365 | PF00069 | 0.306 |
MOD_GSK3_1 | 447 | 454 | PF00069 | 0.590 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.272 |
MOD_N-GLC_2 | 464 | 466 | PF02516 | 0.490 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.297 |
MOD_NEK2_1 | 243 | 248 | PF00069 | 0.492 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.267 |
MOD_NEK2_1 | 330 | 335 | PF00069 | 0.497 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.315 |
MOD_NEK2_1 | 449 | 454 | PF00069 | 0.612 |
MOD_NEK2_2 | 132 | 137 | PF00069 | 0.280 |
MOD_PIKK_1 | 103 | 109 | PF00454 | 0.373 |
MOD_PIKK_1 | 206 | 212 | PF00454 | 0.252 |
MOD_PIKK_1 | 243 | 249 | PF00454 | 0.485 |
MOD_PIKK_1 | 76 | 82 | PF00454 | 0.274 |
MOD_PKA_1 | 218 | 224 | PF00069 | 0.249 |
MOD_PKA_1 | 239 | 245 | PF00069 | 0.461 |
MOD_PKA_1 | 475 | 481 | PF00069 | 0.671 |
MOD_PKA_2 | 218 | 224 | PF00069 | 0.236 |
MOD_PKA_2 | 238 | 244 | PF00069 | 0.683 |
MOD_PKA_2 | 475 | 481 | PF00069 | 0.514 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.305 |
MOD_Plk_1 | 311 | 317 | PF00069 | 0.544 |
MOD_Plk_1 | 340 | 346 | PF00069 | 0.352 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.240 |
MOD_Plk_2-3 | 326 | 332 | PF00069 | 0.276 |
MOD_Plk_2-3 | 65 | 71 | PF00069 | 0.340 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.383 |
MOD_Plk_4 | 239 | 245 | PF00069 | 0.665 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.277 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.325 |
MOD_Plk_4 | 348 | 354 | PF00069 | 0.311 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.454 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.317 |
MOD_SUMO_for_1 | 36 | 39 | PF00179 | 0.383 |
TRG_DiLeu_BaEn_1 | 25 | 30 | PF01217 | 0.302 |
TRG_DiLeu_BaLyEn_6 | 269 | 274 | PF01217 | 0.446 |
TRG_DiLeu_BaLyEn_6 | 332 | 337 | PF01217 | 0.308 |
TRG_DiLeu_BaLyEn_6 | 383 | 388 | PF01217 | 0.491 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 296 | 299 | PF00928 | 0.438 |
TRG_ER_diArg_1 | 218 | 220 | PF00400 | 0.248 |
TRG_ER_diArg_1 | 75 | 77 | PF00400 | 0.259 |
TRG_Pf-PMV_PEXEL_1 | 229 | 233 | PF00026 | 0.330 |
TRG_Pf-PMV_PEXEL_1 | 272 | 277 | PF00026 | 0.357 |
TRG_Pf-PMV_PEXEL_1 | 76 | 80 | PF00026 | 0.428 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2S2 | Leptomonas seymouri | 66% | 90% |
A0A0S4JTJ8 | Bodo saltans | 30% | 100% |
A0A1X0NTP1 | Trypanosomatidae | 51% | 86% |
A0A3Q8IB30 | Leishmania donovani | 33% | 100% |
A0A3Q8IB74 | Leishmania donovani | 29% | 100% |
A0A3R7MKJ1 | Trypanosoma rangeli | 45% | 92% |
A0A3S5H528 | Leishmania donovani | 25% | 100% |
A0A3S7WTN9 | Leishmania donovani | 34% | 100% |
A0A3S7WUE7 | Leishmania donovani | 88% | 90% |
A0A3S7WWE7 | Leishmania donovani | 25% | 100% |
A4H3D2 | Leishmania braziliensis | 23% | 100% |
A4H3J3 | Leishmania braziliensis | 25% | 100% |
A4H8C4 | Leishmania braziliensis | 34% | 100% |
A4H9L8 | Leishmania braziliensis | 33% | 100% |
A4HBL4 | Leishmania braziliensis | 25% | 100% |
A4HRT2 | Leishmania infantum | 25% | 100% |
A4HWP5 | Leishmania infantum | 34% | 100% |
A4HX71 | Leishmania infantum | 88% | 90% |
A4HXY2 | Leishmania infantum | 33% | 100% |
A4HZA2 | Leishmania infantum | 25% | 100% |
C9ZTU6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 92% |
E9ACB1 | Leishmania major | 24% | 100% |
E9ACG8 | Leishmania major | 25% | 100% |
E9AGS0 | Leishmania infantum | 29% | 100% |
E9AJJ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9AKZ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AQF3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9ARC8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 90% |
E9ARP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9ARW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AUY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
O80673 | Arabidopsis thaliana | 29% | 87% |
P00518 | Oryctolagus cuniculus | 29% | 100% |
P07934 | Mus musculus | 29% | 100% |
P13286 | Rattus norvegicus | 30% | 100% |
Q16816 | Homo sapiens | 29% | 100% |
Q27687 | Leishmania major | 32% | 100% |
Q4QCK0 | Leishmania major | 24% | 100% |
Q4QDK3 | Leishmania major | 29% | 100% |
Q4QEJ2 | Leishmania major | 87% | 100% |
Q4QF23 | Leishmania major | 34% | 100% |
Q4QIV8 | Leishmania major | 24% | 100% |
Q9LET1 | Arabidopsis thaliana | 28% | 86% |
V5BH88 | Trypanosoma cruzi | 45% | 92% |